nodes	percent_of_prediction	percent_of_DWPC	metapath
Salbutamol—CYP3A4—breast cancer	0.272	1	CbGaD
Salbutamol—CYP3A4—Exemestane—breast cancer	0.0559	0.133	CbGbCtD
Salbutamol—CYP3A4—Letrozole—breast cancer	0.0475	0.113	CbGbCtD
Salbutamol—CYP3A4—Anastrozole—breast cancer	0.0424	0.101	CbGbCtD
Salbutamol—CYP3A4—Toremifene—breast cancer	0.0388	0.0921	CbGbCtD
Salbutamol—CYP3A4—Fulvestrant—breast cancer	0.036	0.0856	CbGbCtD
Salbutamol—CYP3A4—Thiotepa—breast cancer	0.0321	0.0763	CbGbCtD
Salbutamol—CYP3A4—Ixabepilone—breast cancer	0.0294	0.0698	CbGbCtD
Salbutamol—CYP3A4—Lapatinib—breast cancer	0.0283	0.0672	CbGbCtD
Salbutamol—CYP3A4—Raloxifene—breast cancer	0.0214	0.0509	CbGbCtD
Salbutamol—CYP3A4—Vinorelbine—breast cancer	0.0157	0.0373	CbGbCtD
Salbutamol—CYP3A4—Tamoxifen—breast cancer	0.0142	0.0336	CbGbCtD
Salbutamol—CYP3A4—Mitoxantrone—breast cancer	0.0138	0.0328	CbGbCtD
Salbutamol—CYP3A4—Paclitaxel—breast cancer	0.011	0.0262	CbGbCtD
Salbutamol—CYP3A4—Irinotecan—breast cancer	0.0109	0.0258	CbGbCtD
Salbutamol—CYP3A4—Vinblastine—breast cancer	0.00966	0.023	CbGbCtD
Salbutamol—CYP3A4—Docetaxel—breast cancer	0.00797	0.0189	CbGbCtD
Salbutamol—CYP3A4—Doxorubicin—breast cancer	0.00594	0.0141	CbGbCtD
Salbutamol—Terbutaline—BCHE—breast cancer	0.000699	0.228	CrCbGaD
Salbutamol—Clenbuterol—TNF—breast cancer	0.000542	0.177	CrCbGaD
Salbutamol—Clenbuterol—CYP1A1—breast cancer	0.000412	0.135	CrCbGaD
Salbutamol—Carteolol—CYP2D6—breast cancer	0.000357	0.117	CrCbGaD
Salbutamol—Salmeterol—CYP3A4—breast cancer	0.00028	0.0914	CrCbGaD
Salbutamol—Epinephrine—TNF—breast cancer	0.000228	0.0744	CrCbGaD
Salbutamol—Nadolol—ABCB1—breast cancer	0.000227	0.0742	CrCbGaD
Salbutamol—Isoprenaline—CYP1A1—breast cancer	0.000206	0.0673	CrCbGaD
Salbutamol—Epinephrine—CYP3A4—breast cancer	0.000111	0.0361	CrCbGaD
Salbutamol—Dermatitis—Gemcitabine—breast cancer	4.98e-05	0.000183	CcSEcCtD
Salbutamol—Tinnitus—Epirubicin—breast cancer	4.96e-05	0.000183	CcSEcCtD
Salbutamol—Malnutrition—Methotrexate—breast cancer	4.95e-05	0.000182	CcSEcCtD
Salbutamol—Haemoglobin—Doxorubicin—breast cancer	4.95e-05	0.000182	CcSEcCtD
Salbutamol—Headache—Gemcitabine—breast cancer	4.95e-05	0.000182	CcSEcCtD
Salbutamol—Musculoskeletal discomfort—Capecitabine—breast cancer	4.95e-05	0.000182	CcSEcCtD
Salbutamol—Flushing—Epirubicin—breast cancer	4.94e-05	0.000182	CcSEcCtD
Salbutamol—Cardiac disorder—Epirubicin—breast cancer	4.94e-05	0.000182	CcSEcCtD
Salbutamol—Vomiting—Fluorouracil—breast cancer	4.94e-05	0.000182	CcSEcCtD
Salbutamol—Rhinitis—Doxorubicin—breast cancer	4.94e-05	0.000182	CcSEcCtD
Salbutamol—Dyspepsia—Docetaxel—breast cancer	4.94e-05	0.000182	CcSEcCtD
Salbutamol—Haemorrhage—Doxorubicin—breast cancer	4.93e-05	0.000181	CcSEcCtD
Salbutamol—Insomnia—Capecitabine—breast cancer	4.91e-05	0.000181	CcSEcCtD
Salbutamol—Hypoaesthesia—Doxorubicin—breast cancer	4.9e-05	0.00018	CcSEcCtD
Salbutamol—Rash—Fluorouracil—breast cancer	4.9e-05	0.00018	CcSEcCtD
Salbutamol—Dermatitis—Fluorouracil—breast cancer	4.89e-05	0.00018	CcSEcCtD
Salbutamol—Pharyngitis—Doxorubicin—breast cancer	4.89e-05	0.00018	CcSEcCtD
Salbutamol—Paraesthesia—Capecitabine—breast cancer	4.88e-05	0.000179	CcSEcCtD
Salbutamol—Decreased appetite—Docetaxel—breast cancer	4.88e-05	0.000179	CcSEcCtD
Salbutamol—Hypersensitivity—Paclitaxel—breast cancer	4.88e-05	0.000179	CcSEcCtD
Salbutamol—Headache—Fluorouracil—breast cancer	4.87e-05	0.000179	CcSEcCtD
Salbutamol—Urinary tract disorder—Doxorubicin—breast cancer	4.87e-05	0.000179	CcSEcCtD
Salbutamol—Dysgeusia—Methotrexate—breast cancer	4.85e-05	0.000179	CcSEcCtD
Salbutamol—Gastrointestinal disorder—Docetaxel—breast cancer	4.84e-05	0.000178	CcSEcCtD
Salbutamol—Connective tissue disorder—Doxorubicin—breast cancer	4.84e-05	0.000178	CcSEcCtD
Salbutamol—Dyspnoea—Capecitabine—breast cancer	4.84e-05	0.000178	CcSEcCtD
Salbutamol—Fatigue—Docetaxel—breast cancer	4.84e-05	0.000178	CcSEcCtD
Salbutamol—Angiopathy—Epirubicin—breast cancer	4.83e-05	0.000178	CcSEcCtD
Salbutamol—Urethral disorder—Doxorubicin—breast cancer	4.83e-05	0.000178	CcSEcCtD
Salbutamol—Nausea—Mitoxantrone—breast cancer	4.82e-05	0.000177	CcSEcCtD
Salbutamol—Nausea—Irinotecan—breast cancer	4.82e-05	0.000177	CcSEcCtD
Salbutamol—Immune system disorder—Epirubicin—breast cancer	4.81e-05	0.000177	CcSEcCtD
Salbutamol—Mediastinal disorder—Epirubicin—breast cancer	4.8e-05	0.000177	CcSEcCtD
Salbutamol—Pain—Docetaxel—breast cancer	4.8e-05	0.000177	CcSEcCtD
Salbutamol—Constipation—Docetaxel—breast cancer	4.8e-05	0.000177	CcSEcCtD
Salbutamol—Back pain—Methotrexate—breast cancer	4.79e-05	0.000176	CcSEcCtD
Salbutamol—Dyspepsia—Capecitabine—breast cancer	4.78e-05	0.000176	CcSEcCtD
Salbutamol—Chills—Epirubicin—breast cancer	4.78e-05	0.000176	CcSEcCtD
Salbutamol—Arrhythmia—Epirubicin—breast cancer	4.76e-05	0.000175	CcSEcCtD
Salbutamol—Asthenia—Paclitaxel—breast cancer	4.75e-05	0.000175	CcSEcCtD
Salbutamol—Decreased appetite—Capecitabine—breast cancer	4.72e-05	0.000174	CcSEcCtD
Salbutamol—Nausea—Gemcitabine—breast cancer	4.69e-05	0.000173	CcSEcCtD
Salbutamol—Gastrointestinal disorder—Capecitabine—breast cancer	4.69e-05	0.000173	CcSEcCtD
Salbutamol—Fatigue—Capecitabine—breast cancer	4.68e-05	0.000172	CcSEcCtD
Salbutamol—Pruritus—Paclitaxel—breast cancer	4.68e-05	0.000172	CcSEcCtD
Salbutamol—Mental disorder—Epirubicin—breast cancer	4.66e-05	0.000172	CcSEcCtD
Salbutamol—Pain—Capecitabine—breast cancer	4.64e-05	0.000171	CcSEcCtD
Salbutamol—Constipation—Capecitabine—breast cancer	4.64e-05	0.000171	CcSEcCtD
Salbutamol—Malnutrition—Epirubicin—breast cancer	4.64e-05	0.000171	CcSEcCtD
Salbutamol—Feeling abnormal—Docetaxel—breast cancer	4.62e-05	0.00017	CcSEcCtD
Salbutamol—Nausea—Fluorouracil—breast cancer	4.62e-05	0.00017	CcSEcCtD
Salbutamol—Ill-defined disorder—Methotrexate—breast cancer	4.6e-05	0.000169	CcSEcCtD
Salbutamol—Tinnitus—Doxorubicin—breast cancer	4.59e-05	0.000169	CcSEcCtD
Salbutamol—Gastrointestinal pain—Docetaxel—breast cancer	4.59e-05	0.000169	CcSEcCtD
Salbutamol—Flushing—Doxorubicin—breast cancer	4.57e-05	0.000168	CcSEcCtD
Salbutamol—Cardiac disorder—Doxorubicin—breast cancer	4.57e-05	0.000168	CcSEcCtD
Salbutamol—Flatulence—Epirubicin—breast cancer	4.57e-05	0.000168	CcSEcCtD
Salbutamol—Tension—Epirubicin—breast cancer	4.55e-05	0.000167	CcSEcCtD
Salbutamol—Dysgeusia—Epirubicin—breast cancer	4.54e-05	0.000167	CcSEcCtD
Salbutamol—Diarrhoea—Paclitaxel—breast cancer	4.53e-05	0.000167	CcSEcCtD
Salbutamol—Nervousness—Epirubicin—breast cancer	4.5e-05	0.000166	CcSEcCtD
Salbutamol—Back pain—Epirubicin—breast cancer	4.48e-05	0.000165	CcSEcCtD
Salbutamol—Feeling abnormal—Capecitabine—breast cancer	4.47e-05	0.000165	CcSEcCtD
Salbutamol—Angiopathy—Doxorubicin—breast cancer	4.47e-05	0.000165	CcSEcCtD
Salbutamol—Malaise—Methotrexate—breast cancer	4.47e-05	0.000164	CcSEcCtD
Salbutamol—Muscle spasms—Epirubicin—breast cancer	4.46e-05	0.000164	CcSEcCtD
Salbutamol—Immune system disorder—Doxorubicin—breast cancer	4.45e-05	0.000164	CcSEcCtD
Salbutamol—Vertigo—Methotrexate—breast cancer	4.45e-05	0.000164	CcSEcCtD
Salbutamol—Gastrointestinal pain—Capecitabine—breast cancer	4.44e-05	0.000163	CcSEcCtD
Salbutamol—Mediastinal disorder—Doxorubicin—breast cancer	4.44e-05	0.000163	CcSEcCtD
Salbutamol—Body temperature increased—Docetaxel—breast cancer	4.43e-05	0.000163	CcSEcCtD
Salbutamol—Abdominal pain—Docetaxel—breast cancer	4.43e-05	0.000163	CcSEcCtD
Salbutamol—Chills—Doxorubicin—breast cancer	4.42e-05	0.000163	CcSEcCtD
Salbutamol—Arrhythmia—Doxorubicin—breast cancer	4.4e-05	0.000162	CcSEcCtD
Salbutamol—Dizziness—Paclitaxel—breast cancer	4.38e-05	0.000161	CcSEcCtD
Salbutamol—Cough—Methotrexate—breast cancer	4.32e-05	0.000159	CcSEcCtD
Salbutamol—Mental disorder—Doxorubicin—breast cancer	4.32e-05	0.000159	CcSEcCtD
Salbutamol—Urticaria—Capecitabine—breast cancer	4.31e-05	0.000159	CcSEcCtD
Salbutamol—Ill-defined disorder—Epirubicin—breast cancer	4.3e-05	0.000158	CcSEcCtD
Salbutamol—Abdominal pain—Capecitabine—breast cancer	4.29e-05	0.000158	CcSEcCtD
Salbutamol—Body temperature increased—Capecitabine—breast cancer	4.29e-05	0.000158	CcSEcCtD
Salbutamol—Malnutrition—Doxorubicin—breast cancer	4.29e-05	0.000158	CcSEcCtD
Salbutamol—Agitation—Epirubicin—breast cancer	4.26e-05	0.000157	CcSEcCtD
Salbutamol—Flatulence—Doxorubicin—breast cancer	4.23e-05	0.000156	CcSEcCtD
Salbutamol—Arthralgia—Methotrexate—breast cancer	4.22e-05	0.000155	CcSEcCtD
Salbutamol—Myalgia—Methotrexate—breast cancer	4.22e-05	0.000155	CcSEcCtD
Salbutamol—Chest pain—Methotrexate—breast cancer	4.22e-05	0.000155	CcSEcCtD
Salbutamol—Tension—Doxorubicin—breast cancer	4.21e-05	0.000155	CcSEcCtD
Salbutamol—Vomiting—Paclitaxel—breast cancer	4.21e-05	0.000155	CcSEcCtD
Salbutamol—Dysgeusia—Doxorubicin—breast cancer	4.2e-05	0.000155	CcSEcCtD
Salbutamol—Malaise—Epirubicin—breast cancer	4.18e-05	0.000154	CcSEcCtD
Salbutamol—Rash—Paclitaxel—breast cancer	4.17e-05	0.000154	CcSEcCtD
Salbutamol—Dermatitis—Paclitaxel—breast cancer	4.17e-05	0.000153	CcSEcCtD
Salbutamol—Discomfort—Methotrexate—breast cancer	4.17e-05	0.000153	CcSEcCtD
Salbutamol—Nervousness—Doxorubicin—breast cancer	4.17e-05	0.000153	CcSEcCtD
Salbutamol—Vertigo—Epirubicin—breast cancer	4.16e-05	0.000153	CcSEcCtD
Salbutamol—Syncope—Epirubicin—breast cancer	4.16e-05	0.000153	CcSEcCtD
Salbutamol—Back pain—Doxorubicin—breast cancer	4.15e-05	0.000153	CcSEcCtD
Salbutamol—Headache—Paclitaxel—breast cancer	4.15e-05	0.000153	CcSEcCtD
Salbutamol—Hypersensitivity—Docetaxel—breast cancer	4.13e-05	0.000152	CcSEcCtD
Salbutamol—Muscle spasms—Doxorubicin—breast cancer	4.12e-05	0.000152	CcSEcCtD
Salbutamol—Palpitations—Epirubicin—breast cancer	4.1e-05	0.000151	CcSEcCtD
Salbutamol—Loss of consciousness—Epirubicin—breast cancer	4.07e-05	0.00015	CcSEcCtD
Salbutamol—Cough—Epirubicin—breast cancer	4.04e-05	0.000149	CcSEcCtD
Salbutamol—Anaphylactic shock—Methotrexate—breast cancer	4.04e-05	0.000149	CcSEcCtD
Salbutamol—Asthenia—Docetaxel—breast cancer	4.02e-05	0.000148	CcSEcCtD
Salbutamol—Infection—Methotrexate—breast cancer	4.02e-05	0.000148	CcSEcCtD
Salbutamol—Hypertension—Epirubicin—breast cancer	4e-05	0.000147	CcSEcCtD
Salbutamol—Hypersensitivity—Capecitabine—breast cancer	4e-05	0.000147	CcSEcCtD
Salbutamol—Ill-defined disorder—Doxorubicin—breast cancer	3.98e-05	0.000146	CcSEcCtD
Salbutamol—Pruritus—Docetaxel—breast cancer	3.97e-05	0.000146	CcSEcCtD
Salbutamol—Nervous system disorder—Methotrexate—breast cancer	3.96e-05	0.000146	CcSEcCtD
Salbutamol—Myalgia—Epirubicin—breast cancer	3.95e-05	0.000145	CcSEcCtD
Salbutamol—Arthralgia—Epirubicin—breast cancer	3.95e-05	0.000145	CcSEcCtD
Salbutamol—Chest pain—Epirubicin—breast cancer	3.95e-05	0.000145	CcSEcCtD
Salbutamol—Agitation—Doxorubicin—breast cancer	3.94e-05	0.000145	CcSEcCtD
Salbutamol—Anxiety—Epirubicin—breast cancer	3.93e-05	0.000145	CcSEcCtD
Salbutamol—Nausea—Paclitaxel—breast cancer	3.93e-05	0.000145	CcSEcCtD
Salbutamol—Skin disorder—Methotrexate—breast cancer	3.93e-05	0.000145	CcSEcCtD
Salbutamol—Hyperhidrosis—Methotrexate—breast cancer	3.91e-05	0.000144	CcSEcCtD
Salbutamol—Discomfort—Epirubicin—breast cancer	3.9e-05	0.000143	CcSEcCtD
Salbutamol—Asthenia—Capecitabine—breast cancer	3.9e-05	0.000143	CcSEcCtD
Salbutamol—Malaise—Doxorubicin—breast cancer	3.87e-05	0.000142	CcSEcCtD
Salbutamol—Dry mouth—Epirubicin—breast cancer	3.86e-05	0.000142	CcSEcCtD
Salbutamol—Vertigo—Doxorubicin—breast cancer	3.85e-05	0.000142	CcSEcCtD
Salbutamol—Anorexia—Methotrexate—breast cancer	3.85e-05	0.000142	CcSEcCtD
Salbutamol—Syncope—Doxorubicin—breast cancer	3.85e-05	0.000142	CcSEcCtD
Salbutamol—Pruritus—Capecitabine—breast cancer	3.84e-05	0.000141	CcSEcCtD
Salbutamol—Diarrhoea—Docetaxel—breast cancer	3.84e-05	0.000141	CcSEcCtD
Salbutamol—Palpitations—Doxorubicin—breast cancer	3.79e-05	0.000139	CcSEcCtD
Salbutamol—Anaphylactic shock—Epirubicin—breast cancer	3.78e-05	0.000139	CcSEcCtD
Salbutamol—Oedema—Epirubicin—breast cancer	3.78e-05	0.000139	CcSEcCtD
Salbutamol—Hypotension—Methotrexate—breast cancer	3.78e-05	0.000139	CcSEcCtD
Salbutamol—Loss of consciousness—Doxorubicin—breast cancer	3.77e-05	0.000139	CcSEcCtD
Salbutamol—Infection—Epirubicin—breast cancer	3.76e-05	0.000138	CcSEcCtD
Salbutamol—Cough—Doxorubicin—breast cancer	3.74e-05	0.000138	CcSEcCtD
Salbutamol—Shock—Epirubicin—breast cancer	3.72e-05	0.000137	CcSEcCtD
Salbutamol—Diarrhoea—Capecitabine—breast cancer	3.72e-05	0.000137	CcSEcCtD
Salbutamol—Nervous system disorder—Epirubicin—breast cancer	3.71e-05	0.000137	CcSEcCtD
Salbutamol—Dizziness—Docetaxel—breast cancer	3.71e-05	0.000136	CcSEcCtD
Salbutamol—Hypertension—Doxorubicin—breast cancer	3.7e-05	0.000136	CcSEcCtD
Salbutamol—Tachycardia—Epirubicin—breast cancer	3.69e-05	0.000136	CcSEcCtD
Salbutamol—Musculoskeletal discomfort—Methotrexate—breast cancer	3.68e-05	0.000136	CcSEcCtD
Salbutamol—Skin disorder—Epirubicin—breast cancer	3.67e-05	0.000135	CcSEcCtD
Salbutamol—Hyperhidrosis—Epirubicin—breast cancer	3.66e-05	0.000135	CcSEcCtD
Salbutamol—Insomnia—Methotrexate—breast cancer	3.66e-05	0.000135	CcSEcCtD
Salbutamol—Arthralgia—Doxorubicin—breast cancer	3.65e-05	0.000134	CcSEcCtD
Salbutamol—Chest pain—Doxorubicin—breast cancer	3.65e-05	0.000134	CcSEcCtD
Salbutamol—Myalgia—Doxorubicin—breast cancer	3.65e-05	0.000134	CcSEcCtD
Salbutamol—Anxiety—Doxorubicin—breast cancer	3.64e-05	0.000134	CcSEcCtD
Salbutamol—Paraesthesia—Methotrexate—breast cancer	3.63e-05	0.000134	CcSEcCtD
Salbutamol—Discomfort—Doxorubicin—breast cancer	3.61e-05	0.000133	CcSEcCtD
Salbutamol—Anorexia—Epirubicin—breast cancer	3.61e-05	0.000133	CcSEcCtD
Salbutamol—Dyspnoea—Methotrexate—breast cancer	3.6e-05	0.000133	CcSEcCtD
Salbutamol—Somnolence—Methotrexate—breast cancer	3.59e-05	0.000132	CcSEcCtD
Salbutamol—Dizziness—Capecitabine—breast cancer	3.59e-05	0.000132	CcSEcCtD
Salbutamol—Dry mouth—Doxorubicin—breast cancer	3.57e-05	0.000131	CcSEcCtD
Salbutamol—Vomiting—Docetaxel—breast cancer	3.57e-05	0.000131	CcSEcCtD
Salbutamol—Dyspepsia—Methotrexate—breast cancer	3.56e-05	0.000131	CcSEcCtD
Salbutamol—Rash—Docetaxel—breast cancer	3.54e-05	0.00013	CcSEcCtD
Salbutamol—Hypotension—Epirubicin—breast cancer	3.53e-05	0.00013	CcSEcCtD
Salbutamol—Dermatitis—Docetaxel—breast cancer	3.53e-05	0.00013	CcSEcCtD
Salbutamol—Decreased appetite—Methotrexate—breast cancer	3.51e-05	0.000129	CcSEcCtD
Salbutamol—Headache—Docetaxel—breast cancer	3.51e-05	0.000129	CcSEcCtD
Salbutamol—Anaphylactic shock—Doxorubicin—breast cancer	3.5e-05	0.000129	CcSEcCtD
Salbutamol—Oedema—Doxorubicin—breast cancer	3.5e-05	0.000129	CcSEcCtD
Salbutamol—Gastrointestinal disorder—Methotrexate—breast cancer	3.49e-05	0.000128	CcSEcCtD
Salbutamol—Fatigue—Methotrexate—breast cancer	3.49e-05	0.000128	CcSEcCtD
Salbutamol—Infection—Doxorubicin—breast cancer	3.48e-05	0.000128	CcSEcCtD
Salbutamol—Pain—Methotrexate—breast cancer	3.46e-05	0.000127	CcSEcCtD
Salbutamol—Vomiting—Capecitabine—breast cancer	3.45e-05	0.000127	CcSEcCtD
Salbutamol—Musculoskeletal discomfort—Epirubicin—breast cancer	3.45e-05	0.000127	CcSEcCtD
Salbutamol—Shock—Doxorubicin—breast cancer	3.44e-05	0.000127	CcSEcCtD
Salbutamol—Nervous system disorder—Doxorubicin—breast cancer	3.43e-05	0.000126	CcSEcCtD
Salbutamol—Rash—Capecitabine—breast cancer	3.42e-05	0.000126	CcSEcCtD
Salbutamol—Insomnia—Epirubicin—breast cancer	3.42e-05	0.000126	CcSEcCtD
Salbutamol—Dermatitis—Capecitabine—breast cancer	3.42e-05	0.000126	CcSEcCtD
Salbutamol—Tachycardia—Doxorubicin—breast cancer	3.42e-05	0.000126	CcSEcCtD
Salbutamol—Headache—Capecitabine—breast cancer	3.4e-05	0.000125	CcSEcCtD
Salbutamol—Skin disorder—Doxorubicin—breast cancer	3.4e-05	0.000125	CcSEcCtD
Salbutamol—Paraesthesia—Epirubicin—breast cancer	3.4e-05	0.000125	CcSEcCtD
Salbutamol—Hyperhidrosis—Doxorubicin—breast cancer	3.38e-05	0.000125	CcSEcCtD
Salbutamol—Dyspnoea—Epirubicin—breast cancer	3.37e-05	0.000124	CcSEcCtD
Salbutamol—Somnolence—Epirubicin—breast cancer	3.36e-05	0.000124	CcSEcCtD
Salbutamol—Anorexia—Doxorubicin—breast cancer	3.34e-05	0.000123	CcSEcCtD
Salbutamol—Nausea—Docetaxel—breast cancer	3.33e-05	0.000123	CcSEcCtD
Salbutamol—Feeling abnormal—Methotrexate—breast cancer	3.33e-05	0.000123	CcSEcCtD
Salbutamol—Dyspepsia—Epirubicin—breast cancer	3.33e-05	0.000123	CcSEcCtD
Salbutamol—Gastrointestinal pain—Methotrexate—breast cancer	3.31e-05	0.000122	CcSEcCtD
Salbutamol—Decreased appetite—Epirubicin—breast cancer	3.29e-05	0.000121	CcSEcCtD
Salbutamol—Hypotension—Doxorubicin—breast cancer	3.27e-05	0.00012	CcSEcCtD
Salbutamol—Gastrointestinal disorder—Epirubicin—breast cancer	3.27e-05	0.00012	CcSEcCtD
Salbutamol—Fatigue—Epirubicin—breast cancer	3.26e-05	0.00012	CcSEcCtD
Salbutamol—Constipation—Epirubicin—breast cancer	3.23e-05	0.000119	CcSEcCtD
Salbutamol—Pain—Epirubicin—breast cancer	3.23e-05	0.000119	CcSEcCtD
Salbutamol—Nausea—Capecitabine—breast cancer	3.23e-05	0.000119	CcSEcCtD
Salbutamol—Urticaria—Methotrexate—breast cancer	3.21e-05	0.000118	CcSEcCtD
Salbutamol—Body temperature increased—Methotrexate—breast cancer	3.2e-05	0.000118	CcSEcCtD
Salbutamol—Abdominal pain—Methotrexate—breast cancer	3.2e-05	0.000118	CcSEcCtD
Salbutamol—Musculoskeletal discomfort—Doxorubicin—breast cancer	3.19e-05	0.000117	CcSEcCtD
Salbutamol—Insomnia—Doxorubicin—breast cancer	3.17e-05	0.000117	CcSEcCtD
Salbutamol—Paraesthesia—Doxorubicin—breast cancer	3.14e-05	0.000116	CcSEcCtD
Salbutamol—Dyspnoea—Doxorubicin—breast cancer	3.12e-05	0.000115	CcSEcCtD
Salbutamol—Feeling abnormal—Epirubicin—breast cancer	3.12e-05	0.000115	CcSEcCtD
Salbutamol—Somnolence—Doxorubicin—breast cancer	3.11e-05	0.000115	CcSEcCtD
Salbutamol—Gastrointestinal pain—Epirubicin—breast cancer	3.09e-05	0.000114	CcSEcCtD
Salbutamol—Dyspepsia—Doxorubicin—breast cancer	3.08e-05	0.000113	CcSEcCtD
Salbutamol—Decreased appetite—Doxorubicin—breast cancer	3.04e-05	0.000112	CcSEcCtD
Salbutamol—Gastrointestinal disorder—Doxorubicin—breast cancer	3.02e-05	0.000111	CcSEcCtD
Salbutamol—Fatigue—Doxorubicin—breast cancer	3.02e-05	0.000111	CcSEcCtD
Salbutamol—Urticaria—Epirubicin—breast cancer	3.01e-05	0.000111	CcSEcCtD
Salbutamol—Pain—Doxorubicin—breast cancer	2.99e-05	0.00011	CcSEcCtD
Salbutamol—Constipation—Doxorubicin—breast cancer	2.99e-05	0.00011	CcSEcCtD
Salbutamol—Body temperature increased—Epirubicin—breast cancer	2.99e-05	0.00011	CcSEcCtD
Salbutamol—Abdominal pain—Epirubicin—breast cancer	2.99e-05	0.00011	CcSEcCtD
Salbutamol—Hypersensitivity—Methotrexate—breast cancer	2.98e-05	0.00011	CcSEcCtD
Salbutamol—Asthenia—Methotrexate—breast cancer	2.9e-05	0.000107	CcSEcCtD
Salbutamol—Feeling abnormal—Doxorubicin—breast cancer	2.88e-05	0.000106	CcSEcCtD
Salbutamol—Gastrointestinal pain—Doxorubicin—breast cancer	2.86e-05	0.000105	CcSEcCtD
Salbutamol—Pruritus—Methotrexate—breast cancer	2.86e-05	0.000105	CcSEcCtD
Salbutamol—Hypersensitivity—Epirubicin—breast cancer	2.79e-05	0.000103	CcSEcCtD
Salbutamol—Urticaria—Doxorubicin—breast cancer	2.78e-05	0.000102	CcSEcCtD
Salbutamol—Body temperature increased—Doxorubicin—breast cancer	2.77e-05	0.000102	CcSEcCtD
Salbutamol—Abdominal pain—Doxorubicin—breast cancer	2.77e-05	0.000102	CcSEcCtD
Salbutamol—Diarrhoea—Methotrexate—breast cancer	2.77e-05	0.000102	CcSEcCtD
Salbutamol—Asthenia—Epirubicin—breast cancer	2.71e-05	9.99e-05	CcSEcCtD
Salbutamol—Pruritus—Epirubicin—breast cancer	2.68e-05	9.85e-05	CcSEcCtD
Salbutamol—Dizziness—Methotrexate—breast cancer	2.67e-05	9.84e-05	CcSEcCtD
Salbutamol—Diarrhoea—Epirubicin—breast cancer	2.59e-05	9.53e-05	CcSEcCtD
Salbutamol—Hypersensitivity—Doxorubicin—breast cancer	2.58e-05	9.49e-05	CcSEcCtD
Salbutamol—Vomiting—Methotrexate—breast cancer	2.57e-05	9.46e-05	CcSEcCtD
Salbutamol—Rash—Methotrexate—breast cancer	2.55e-05	9.38e-05	CcSEcCtD
Salbutamol—Dermatitis—Methotrexate—breast cancer	2.55e-05	9.37e-05	CcSEcCtD
Salbutamol—Headache—Methotrexate—breast cancer	2.53e-05	9.32e-05	CcSEcCtD
Salbutamol—Asthenia—Doxorubicin—breast cancer	2.51e-05	9.24e-05	CcSEcCtD
Salbutamol—Dizziness—Epirubicin—breast cancer	2.5e-05	9.21e-05	CcSEcCtD
Salbutamol—Pruritus—Doxorubicin—breast cancer	2.48e-05	9.11e-05	CcSEcCtD
Salbutamol—Vomiting—Epirubicin—breast cancer	2.41e-05	8.85e-05	CcSEcCtD
Salbutamol—Nausea—Methotrexate—breast cancer	2.4e-05	8.84e-05	CcSEcCtD
Salbutamol—Diarrhoea—Doxorubicin—breast cancer	2.39e-05	8.81e-05	CcSEcCtD
Salbutamol—Rash—Epirubicin—breast cancer	2.39e-05	8.78e-05	CcSEcCtD
Salbutamol—Dermatitis—Epirubicin—breast cancer	2.38e-05	8.77e-05	CcSEcCtD
Salbutamol—Headache—Epirubicin—breast cancer	2.37e-05	8.72e-05	CcSEcCtD
Salbutamol—Dizziness—Doxorubicin—breast cancer	2.31e-05	8.52e-05	CcSEcCtD
Salbutamol—Nausea—Epirubicin—breast cancer	2.25e-05	8.27e-05	CcSEcCtD
Salbutamol—Vomiting—Doxorubicin—breast cancer	2.23e-05	8.19e-05	CcSEcCtD
Salbutamol—Rash—Doxorubicin—breast cancer	2.21e-05	8.12e-05	CcSEcCtD
Salbutamol—Dermatitis—Doxorubicin—breast cancer	2.2e-05	8.11e-05	CcSEcCtD
Salbutamol—Headache—Doxorubicin—breast cancer	2.19e-05	8.07e-05	CcSEcCtD
Salbutamol—Nausea—Doxorubicin—breast cancer	2.08e-05	7.65e-05	CcSEcCtD
Salbutamol—CYP3A4—Metabolism—ANGPTL4—breast cancer	9.94e-06	0.000309	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—AKT2—breast cancer	9.89e-06	0.000307	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—FGF10—breast cancer	9.83e-06	0.000306	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—PIK3CD—breast cancer	9.71e-06	0.000302	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—PDGFA—breast cancer	9.7e-06	0.000301	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—TGFBR2—breast cancer	9.56e-06	0.000297	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—PIK3CD—breast cancer	9.5e-06	0.000295	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—PDGFA—breast cancer	9.49e-06	0.000295	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—HADHB—breast cancer	9.43e-06	0.000293	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—GPI—breast cancer	9.43e-06	0.000293	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—ITPR1—breast cancer	9.41e-06	0.000292	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—TGFBR2—breast cancer	9.35e-06	0.000291	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—ERBB4—breast cancer	9.35e-06	0.00029	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—MMP3—breast cancer	9.35e-06	0.00029	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—STAT5A—breast cancer	9.35e-06	0.00029	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—PIK3CB—breast cancer	9.32e-06	0.00029	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—ITPR1—breast cancer	9.2e-06	0.000286	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—MMP3—breast cancer	9.14e-06	0.000284	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—STAT5A—breast cancer	9.14e-06	0.000284	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—ERBB4—breast cancer	9.14e-06	0.000284	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—PIK3CB—breast cancer	9.12e-06	0.000283	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—SMAD4—breast cancer	9.05e-06	0.000281	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—IGF1R—breast cancer	9e-06	0.00028	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ALDH7A1—breast cancer	8.99e-06	0.000279	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ALDH1A1—breast cancer	8.99e-06	0.000279	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—CXCL8—breast cancer	8.96e-06	0.000278	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—SMAD4—breast cancer	8.85e-06	0.000275	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—HES1—breast cancer	8.84e-06	0.000275	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—IGF1R—breast cancer	8.8e-06	0.000273	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—PLA2G4A—breast cancer	8.79e-06	0.000273	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—NCOR1—breast cancer	8.79e-06	0.000273	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—CXCL8—breast cancer	8.76e-06	0.000272	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—CSF2—breast cancer	8.69e-06	0.00027	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—FGF1—breast cancer	8.69e-06	0.00027	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—RAF1—breast cancer	8.67e-06	0.000269	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—HES1—breast cancer	8.65e-06	0.000269	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—NRG1—breast cancer	8.63e-06	0.000268	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PHGDH—breast cancer	8.62e-06	0.000268	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—FHL2—breast cancer	8.62e-06	0.000268	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—NME1—breast cancer	8.62e-06	0.000268	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ADSL—breast cancer	8.62e-06	0.000268	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—UMPS—breast cancer	8.62e-06	0.000268	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—NCOR1—breast cancer	8.6e-06	0.000267	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—PLA2G4A—breast cancer	8.6e-06	0.000267	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—H2AFX—breast cancer	8.56e-06	0.000266	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—IL2—breast cancer	8.56e-06	0.000266	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—E2F1—breast cancer	8.5e-06	0.000264	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—CSF2—breast cancer	8.5e-06	0.000264	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—FGF1—breast cancer	8.5e-06	0.000264	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—RAF1—breast cancer	8.48e-06	0.000263	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—PIK3CB—breast cancer	8.46e-06	0.000263	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—BRIP1—breast cancer	8.45e-06	0.000263	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—HPSE—breast cancer	8.45e-06	0.000263	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—LDHB—breast cancer	8.45e-06	0.000263	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—NRG1—breast cancer	8.44e-06	0.000262	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—H2AFX—breast cancer	8.38e-06	0.00026	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—IL2—breast cancer	8.37e-06	0.00026	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—E2F1—breast cancer	8.32e-06	0.000258	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—PIK3CB—breast cancer	8.28e-06	0.000257	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—SPP1—breast cancer	8.17e-06	0.000254	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—CXCL8—breast cancer	8.13e-06	0.000253	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—ERBB3—breast cancer	8.08e-06	0.000251	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—FGFR2—breast cancer	8.07e-06	0.000251	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—GSTA3—breast cancer	8.02e-06	0.000249	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—HMMR—breast cancer	8.02e-06	0.000249	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ABCC1—breast cancer	8.02e-06	0.000249	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—SPP1—breast cancer	7.99e-06	0.000248	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—CXCL8—breast cancer	7.96e-06	0.000247	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—ERBB3—breast cancer	7.9e-06	0.000246	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—FGFR2—breast cancer	7.89e-06	0.000245	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—IL2—breast cancer	7.77e-06	0.000241	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PPARGC1B—breast cancer	7.76e-06	0.000241	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—TERT—breast cancer	7.74e-06	0.000241	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—IL2—breast cancer	7.6e-06	0.000236	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—TERT—breast cancer	7.58e-06	0.000235	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—FGFR1—breast cancer	7.52e-06	0.000234	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—HIF1A—breast cancer	7.41e-06	0.00023	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—FGFR1—breast cancer	7.36e-06	0.000229	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—CA9—breast cancer	7.33e-06	0.000228	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—GSTA4—breast cancer	7.33e-06	0.000228	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—HIF1A—breast cancer	7.25e-06	0.000225	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—LEP—breast cancer	7.23e-06	0.000225	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—CAV1—breast cancer	7.16e-06	0.000223	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—GSTA2—breast cancer	7.14e-06	0.000222	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—GPX2—breast cancer	7.14e-06	0.000222	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—KDR—breast cancer	7.08e-06	0.00022	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—LEP—breast cancer	7.07e-06	0.00022	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—SULT1A1—breast cancer	7.06e-06	0.000219	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—GPX4—breast cancer	7.06e-06	0.000219	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—CAV1—breast cancer	7.01e-06	0.000218	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—KDR—breast cancer	6.93e-06	0.000215	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—ESR1—breast cancer	6.9e-06	0.000214	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—GSTA1—breast cancer	6.89e-06	0.000214	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—IDH1—breast cancer	6.89e-06	0.000214	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—FN1—breast cancer	6.82e-06	0.000212	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—NAT2—breast cancer	6.82e-06	0.000212	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—ESR1—breast cancer	6.75e-06	0.00021	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—NFKBIA—breast cancer	6.74e-06	0.000209	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—NOTCH1—breast cancer	6.67e-06	0.000207	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—FN1—breast cancer	6.67e-06	0.000207	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—NFKBIA—breast cancer	6.59e-06	0.000205	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—NOTCH1—breast cancer	6.53e-06	0.000203	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—PIK3CG—breast cancer	6.53e-06	0.000203	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—APC—breast cancer	6.53e-06	0.000203	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—KIT—breast cancer	6.53e-06	0.000203	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—EGF—breast cancer	6.45e-06	0.0002	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—APC—breast cancer	6.38e-06	0.000198	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—PIK3CG—breast cancer	6.38e-06	0.000198	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—KIT—breast cancer	6.38e-06	0.000198	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—EGF—breast cancer	6.31e-06	0.000196	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—MAPK3—breast cancer	6.25e-06	0.000194	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—BRAF—breast cancer	6.13e-06	0.000191	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—MAPK3—breast cancer	6.11e-06	0.00019	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—BRAF—breast cancer	6e-06	0.000186	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—MED12—breast cancer	5.98e-06	0.000186	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—DPYD—breast cancer	5.98e-06	0.000186	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—IGF1—breast cancer	5.97e-06	0.000186	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—AKT2—breast cancer	5.97e-06	0.000185	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—EGFR—breast cancer	5.94e-06	0.000185	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ALDOA—breast cancer	5.88e-06	0.000183	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—IGF1—breast cancer	5.84e-06	0.000182	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—AKT2—breast cancer	5.84e-06	0.000181	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—EGFR—breast cancer	5.82e-06	0.000181	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—PIK3CD—breast cancer	5.74e-06	0.000178	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—NCOA3—breast cancer	5.71e-06	0.000177	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—PIK3CA—breast cancer	5.68e-06	0.000177	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—SERPINE1—breast cancer	5.67e-06	0.000176	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—SLC2A2—breast cancer	5.67e-06	0.000176	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—KRAS—breast cancer	5.62e-06	0.000174	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—PIK3CD—breast cancer	5.61e-06	0.000174	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—PIK3CA—breast cancer	5.56e-06	0.000173	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—CPT1A—breast cancer	5.56e-06	0.000173	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—MTR—breast cancer	5.56e-06	0.000173	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ABCG2—breast cancer	5.56e-06	0.000173	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—SERPINE1—breast cancer	5.55e-06	0.000172	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—KRAS—breast cancer	5.49e-06	0.000171	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—HPGDS—breast cancer	5.45e-06	0.000169	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—NOS3—breast cancer	5.42e-06	0.000168	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—HBA1—breast cancer	5.41e-06	0.000168	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—NOS3—breast cancer	5.3e-06	0.000165	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ACHE—breast cancer	5.28e-06	0.000164	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—GSTT1—breast cancer	5.28e-06	0.000164	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—PIK3CA—breast cancer	5.16e-06	0.00016	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—MDM2—breast cancer	5.14e-06	0.00016	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—RAF1—breast cancer	5.12e-06	0.000159	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—RELA—breast cancer	5.1e-06	0.000158	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—ERBB2—breast cancer	5.07e-06	0.000157	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—PIK3CA—breast cancer	5.05e-06	0.000157	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—MDM2—breast cancer	5.03e-06	0.000156	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—RAF1—breast cancer	5.01e-06	0.000156	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—CYP17A1—breast cancer	5e-06	0.000155	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—MTOR—breast cancer	5e-06	0.000155	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—PIK3CB—breast cancer	5e-06	0.000155	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—RELA—breast cancer	4.99e-06	0.000155	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—ERBB2—breast cancer	4.96e-06	0.000154	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ENO1—breast cancer	4.95e-06	0.000154	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PTGS1—breast cancer	4.95e-06	0.000154	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—PIK3CB—breast cancer	4.89e-06	0.000152	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—MTOR—breast cancer	4.89e-06	0.000152	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—CYP2D6—breast cancer	4.86e-06	0.000151	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—CXCL8—breast cancer	4.8e-06	0.000149	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—HRAS—breast cancer	4.77e-06	0.000148	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—NCOA2—breast cancer	4.77e-06	0.000148	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—CXCL8—breast cancer	4.7e-06	0.000146	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—CDKN1B—breast cancer	4.69e-06	0.000146	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—HRAS—breast cancer	4.67e-06	0.000145	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—AKT1—breast cancer	4.64e-06	0.000144	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—FASN—breast cancer	4.62e-06	0.000144	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—BCHE—breast cancer	4.6e-06	0.000143	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—CASP3—breast cancer	4.6e-06	0.000143	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—IL2—breast cancer	4.59e-06	0.000143	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—CDKN1B—breast cancer	4.59e-06	0.000143	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—IL6—breast cancer	4.57e-06	0.000142	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—SLC5A5—breast cancer	4.55e-06	0.000141	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—AKT1—breast cancer	4.54e-06	0.000141	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—CASP3—breast cancer	4.5e-06	0.00014	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—IL2—breast cancer	4.49e-06	0.00014	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—CCND1—breast cancer	4.48e-06	0.000139	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—IL6—breast cancer	4.47e-06	0.000139	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—JUN—breast cancer	4.47e-06	0.000139	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—CTNNB1—breast cancer	4.43e-06	0.000138	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—SLC2A1—breast cancer	4.39e-06	0.000136	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—NQO1—breast cancer	4.39e-06	0.000136	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—CCND1—breast cancer	4.38e-06	0.000136	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—JUN—breast cancer	4.37e-06	0.000136	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—MMP9—breast cancer	4.35e-06	0.000135	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—CTNNB1—breast cancer	4.34e-06	0.000135	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—CDKN1A—breast cancer	4.33e-06	0.000135	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—PTEN—breast cancer	4.32e-06	0.000134	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—MMP9—breast cancer	4.25e-06	0.000132	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—CDKN1A—breast cancer	4.24e-06	0.000132	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—MAPK8—breast cancer	4.23e-06	0.000131	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—PTEN—breast cancer	4.23e-06	0.000131	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—AKT1—breast cancer	4.21e-06	0.000131	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—CYP1B1—breast cancer	4.21e-06	0.000131	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—MAPK8—breast cancer	4.13e-06	0.000128	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—HSP90AA1—breast cancer	4.13e-06	0.000128	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—AKT1—breast cancer	4.12e-06	0.000128	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—NCOA1—breast cancer	4.02e-06	0.000125	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—SRC—breast cancer	4.01e-06	0.000124	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—STK11—breast cancer	3.96e-06	0.000123	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—CYP19A1—breast cancer	3.96e-06	0.000123	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—SRC—breast cancer	3.92e-06	0.000122	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—VEGFA—breast cancer	3.9e-06	0.000121	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—STAT3—breast cancer	3.86e-06	0.00012	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—VEGFA—breast cancer	3.82e-06	0.000119	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—STAT3—breast cancer	3.78e-06	0.000117	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—MAPK3—breast cancer	3.69e-06	0.000115	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—COMT—breast cancer	3.68e-06	0.000114	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—GSTP1—breast cancer	3.66e-06	0.000114	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—HMOX1—breast cancer	3.61e-06	0.000112	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—MAPK3—breast cancer	3.61e-06	0.000112	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ITPR1—breast cancer	3.6e-06	0.000112	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—MYC—breast cancer	3.59e-06	0.000112	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—TGFB1—breast cancer	3.58e-06	0.000111	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—MYC—breast cancer	3.51e-06	0.000109	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—EGFR—breast cancer	3.51e-06	0.000109	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—TGFB1—breast cancer	3.5e-06	0.000109	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ABCB1—breast cancer	3.47e-06	0.000108	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—EGFR—breast cancer	3.44e-06	0.000107	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—TYMS—breast cancer	3.41e-06	0.000106	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PLA2G4A—breast cancer	3.37e-06	0.000105	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—GSTM1—breast cancer	3.37e-06	0.000105	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—NCOR1—breast cancer	3.37e-06	0.000105	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—KRAS—breast cancer	3.32e-06	0.000103	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—KRAS—breast cancer	3.25e-06	0.000101	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—GPX1—breast cancer	3.22e-06	0.0001	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—CYP1A1—breast cancer	3.19e-06	9.91e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ERCC2—breast cancer	3.16e-06	9.83e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—PIK3CA—breast cancer	3.05e-06	9.47e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—PIK3CA—breast cancer	2.98e-06	9.26e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—MTHFR—breast cancer	2.97e-06	9.24e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—TP53—breast cancer	2.95e-06	9.16e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—TP53—breast cancer	2.88e-06	8.96e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—HRAS—breast cancer	2.82e-06	8.76e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—HRAS—breast cancer	2.76e-06	8.57e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—CAV1—breast cancer	2.74e-06	8.52e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—IL6—breast cancer	2.7e-06	8.39e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—IL6—breast cancer	2.64e-06	8.2e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PIK3CG—breast cancer	2.5e-06	7.76e-05	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—AKT1—breast cancer	2.49e-06	7.74e-05	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—AKT1—breast cancer	2.44e-06	7.57e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PIK3CD—breast cancer	2.2e-06	6.83e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ALB—breast cancer	2.17e-06	6.74e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—NOS3—breast cancer	2.07e-06	6.45e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PIK3CB—breast cancer	1.92e-06	5.95e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PTGS2—breast cancer	1.9e-06	5.9e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PTEN—breast cancer	1.65e-06	5.14e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—PIK3CA—breast cancer	1.17e-06	3.63e-05	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—AKT1—breast cancer	9.54e-07	2.96e-05	CbGpPWpGaD
